Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
Tibet Rhodiola Pharmaceutical Holding Co
Selling, General & Administrative
Tibet Rhodiola Pharmaceutical Holding Co
Selling, General & Administrative Peer Comparison
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
|
Selling, General & Administrative
-¥1.9B
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
-22%
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Selling, General & Administrative
-¥26.8B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-15%
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Selling, General & Administrative
-¥19.3B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-10%
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Selling, General & Administrative
-¥7.3B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-18%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Selling, General & Administrative
-¥1.4B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-15%
|
Huadong Medicine Co Ltd
SZSE:000963
|
Selling, General & Administrative
-¥7.9B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-14%
|
See Also
What is Tibet Rhodiola Pharmaceutical Holding Co's Selling, General & Administrative?
Selling, General & Administrative
-1.9B
CNY
Based on the financial report for Dec 31, 2023, Tibet Rhodiola Pharmaceutical Holding Co's Selling, General & Administrative amounts to -1.9B CNY.
What is Tibet Rhodiola Pharmaceutical Holding Co's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
-22%
Over the last year, the Selling, General & Administrative growth was -22%. The average annual Selling, General & Administrative growth rates for Tibet Rhodiola Pharmaceutical Holding Co have been -36% over the past three years , -28% over the past five years , and -22% over the past ten years .